誉衡药业：2025年前三季度净利润约2.44亿元

Group 1 - The core viewpoint of the news is that Yuheng Pharmaceutical reported its third-quarter performance, showing a decline in revenue but an increase in net profit and earnings per share [1] Group 2 - For the first three quarters of 2025, the company's revenue was approximately 1.665 billion yuan, a year-on-year decrease of 10.36% [1] - The net profit attributable to shareholders was about 244 million yuan, reflecting a year-on-year increase of 32.85% [1] - The basic earnings per share were 0.1111 yuan, which is a year-on-year increase of 33.05% [1] - As of the report date, the market capitalization of Yuheng Pharmaceutical was 7.2 billion yuan [2]